Pivotal role of ABCA1 in reverse cholesterol transport influencing HLD levels and susceptibility to atherosclerosis

Journal of Lipid Research

Volumn 42, Issue 11, 2001, Pages 1717-1726

  Attie, A D ^a   Kastelein, J P ^a   Hayden, M R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Animal models; Genetics; Lipids; Mutations; Transgenics

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN B CONTAINING LIPOPROTEIN; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; LIVER TRIACYLGLYCEROL LIPASE; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PHOSPHOLIPID; PHOSPHOLIPID TRANSFER PROTEIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ATHEROGENESIS; ATHEROSCLEROSIS; BACTERIAL ARTIFICIAL CHROMOSOME; CELLULAR DISTRIBUTION; CHOLESTEROL TRANSPORT; CORONARY ARTERY DISEASE; GENE MUTATION; HETEROZYGOSITY; PHOSPHOLIPID TRANSFER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TANGIER DISEASE; TRANSGENE;

ANIMALS; ARTERIOSCLEROSIS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CHOLESTEROL; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CORONARY DISEASE; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; LIPOPROTEINS, HDL; MUTATION;

EID: 0035205221     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. The amphipathic helix in the exchangeable apolipoproteins: A review of secondary structure and function
2. The role of apolipoprotein AI domains in lipid binding
3. Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein
4. Phospholipid removal during degradation of rat plasma very low density lipoprotein in vitro
5. Plasma lipid transfer proteins
6. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels
7. The molecular basis of abetalipoproteinemia
8. The plasma lecithin: Cholesterol acyltransferase reaction
9. Targeted disruption of the mouse lecithin: Cholesterol acyltransferase (LCAT) gene. Generation of a new animal model for human LCAT deficiency
10. The molecular pathology of lecithin: Cholesterol acyltransferase (LCAT) deficiency syndromes
11. Evaluation of pathways for the cellular uptake of high density lipoprotein cholesterol esters in rabbits
12. Phospholipid and cholesteryl ester transfer activities in plasma from 14 vertebrate species. Relation to atherogenesis susceptibility
13. Characterization of plasma lipoproteins in patients heterozygous for human plasma cholesteryl ester transfer protein (CETP) deficiency: Plasma CETP regulates high-density lipoprotein concentration and composition
14. Increased atherosclerosis in apoE and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression
15. High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin-cholesteryl acyltransferase
16. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia
17. Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes and metabolism
18. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia
19. Lipid transfer proteins, hypertriglyceridemia, and reduced high-density lipoprotein cholesterol
20. Serum lipoproteins and apolipoproteins in rats with streptozotocin-induced diabetes
21. Dissociation of tissue uptake of cholesterol ester from that of apoprotein A-I of rat plasma high density lipoprotein: Selective delivery of cholesterol ester to liver, adrenal, and gonad
22. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor
23. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels
24. Scavenger receptor class B, type I (SR-BI) is the major route for the delivery of high density lipoprotein cholesterol to the steroidogenic pathway in cultured mouse adrenocortical cells
25. Evidence for high-density lipoprotein-free cholesterol as the primary precursor for bile-acid synthesis in man
26. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux
27. Scavenger receptor BI (SR-BI) mediates free cholesterol flux independently of HDL tethering to the cell surface
28. Expression of scavenger receptor BI in COS-7 cells alters cholesterol content and distribution
29. 3H]cholesterol efflux to high and low density lipoproteins is dependent on lipoprotein binding to the receptor
30. Hepatic lipase and HDL metabolism
31. Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo A-I from HDL and subsequent formation of discoidal HDL
32. Mechanism of the hepatic lipase induced accumulation of high-density lipoprotein cholesterol by cells in culture
33. Hepatic lipase deficiency decreases the selective uptake of HDL-cholesteryl esters in vivo
34. Hepatic lipase facilitates the selective uptake of cholesteryl esters from remnant lipoproteins in apoE-deficient mice
35. Cholesterol and hepatic lipoprotein assembly and secretion
36. Subcellular localization of B apoprotein of plasma lipoproteins in rat liver
37. Spontaneous high density lipoprotein deficiency syndrome associated with a Z-linked mutation in chickens
38. Hypercatabolism of lipoprotein-free apolipoprotein A-I in HDL-deficient mutant chickens
39. Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux
40. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease
41. A two-step mechanism for free cholesterol and phospholipid efflux from human vascular cells to apolipoprotein A-1
42. Pathology of Tangier disease
43. The pathology of Tangier disease. A light and electron microscopic study
44. Massive omental reticuloendothelial cell lipid uptake in Tangier disease after splenectomy
45. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1
46. Transport of lipids from Golgi to plasma membrane is defective in Tangier disease patients and ABC1-deficient mice
47. Functional loss of ABCA1 in mice causes severe placental malformation, aberrant lipid distribution, and kidney glomerulonephritis as well as high density lipoprotein cholesterol deficiency
48. Lipoproteins in a nonrecirculating perfusate of rat liver
49. Biosynthesis of lymph and plasma lipoprotein apoproteins by isolated perfused rat liver and intestine
50. Specific binding of apoAI, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1
51. Specific docking of apolipoprotein A-I at the cell surface requires a functional ABCA1 transporter
52. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway
53. Scavenger receptor-BI inhibits ATP-binding cassette transporter 1-mediated cholesterol efflux in macrophages
54. High density lipoprotein (HDL) particle uptake mediated by scavenger receptor class b type 1 results in selective sorting of HDL cholesterol from protein and polarized cholesterol secretion
55. Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution
56. Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins
57. Human hepatic triglyceride lipase expression reduces high density lipoprotein and aortic cholesterol in cholesterol-fed transgenic mice
58. Mild dyslipidemia in mice following targeted inactivation of the hepatic lipase gene
59. Lecithin: Cholesterol acyltransferase overexpression generates hyperalpha-lipoproteinemia and a nonatherogenic lipoprotein pattern in transgenic rabbits
60. Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes
61. Human ABCA1 BAC transgenic mice show increased HDL-C and ApoAI dependent efflux stimulated by an internal promoter containing LXREs in intron 1
62. Regulation and activity of the human ABCA1 gene in transgenic mice
63. Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease
64. ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice
65. Atherosclerosis - An inflammatory disease
66. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study
67. Getting a handle on "good" cholesterol with the high-density lipoprotein receptor
68. Effect of up-regulating individual steps in the reverse cholesterol transport pathway on reverse cholesterol transport in normolipidemic mice
69. Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology
70. Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene
71. Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-defcient mouse
72. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels
73. In vino metabolism of proapolipoprotein A-I in Tangier disease
74. Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency
75. Characterization of high density lipoproteins in patients heterozygous for Tangier disease
76. Tangier disease: Heterozygote detection and linkage analaysis
77. Abnormal concentrations and anomalous distribution of apolipoprotein A-I in Tangier disease
78. Coronary heart disease prevalence and other clinical features in familial high-density lipoprotein deficiency (Tangier disease)
79. Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux
80. Increased arterial wall thickness in subjects with impairment in ABCA1 driven cholesterol efflux